Hye S. Won

Uijeongbu St. Mary's Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Meeting Highlights: The 11th Korean Breast Cancer Society Consensus Conference on Axillary Management in Early Breast Cancer.

Meeting Highlights: The 11th Korean Breast Cancer Society Consensus Conference on Axillary Management in Early Breast Cancer.

Journal: Journal of breast cancer
Published: June 18, 2026

Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone Lymphomas.

Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone Lymphomas.

Journal: Cancers
Published: August 11, 2025

Comprehensive analysis of mortality risk factors in low-grade B-cell lymphoma.

Comprehensive analysis of mortality risk factors in low-grade B-cell lymphoma.

Journal: PloS one
Published: August 04, 2025

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia.

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia.

Journal: Cancer medicine
Published: July 09, 2025

Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer.

Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer.

Journal: Frontiers in oncology
Published: May 31, 2025

IFITM1 Influences Natural Killer Cell-Mediated Cytotoxicity by Modulation of HLA class I Expression in Triple-Negative Breast Cancer Cells.

IFITM1 Influences Natural Killer Cell-Mediated Cytotoxicity by Modulation of HLA class I Expression in Triple-Negative Breast Cancer Cells.

Journal: Cancer research and treatment
Published: April 24, 2025

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).

Journal: Breast (Edinburgh, Scotland)
Published: January 06, 2025

The efficacy of uterine artery embolization for postpartum hemorrhage with placenta accreta spectrum disorder: clinical outcomes in a cohord of 112 pregnant women.

The efficacy of uterine artery embolization for postpartum hemorrhage with placenta accreta spectrum disorder: clinical outcomes in a cohord of 112 pregnant women.

Journal: European radiology
Published: December 31, 2024

Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm.

Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm.

Journal: Experimental and therapeutic medicine
Published: November 07, 2024

FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient.

FDG PET Images of Pseudoprogression After Nivolumab-FOLFOX Chemotherapy in a Gastric Cancer Patient.

Journal: Clinical nuclear medicine
Published: November 01, 2024

Reduced risk of lymphedema after immediate breast reconstruction in breast cancer: a retrospective nationwide study.

Reduced risk of lymphedema after immediate breast reconstruction in breast cancer: a retrospective nationwide study.

Journal: Scientific reports
Published: May 21, 2024

P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells.

P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells.

Journal: Cancer genomics & proteomics
Published: May 13, 2024
Showing 1-12 of 38

Last Updated: 09/26/2026